MariMed Inc. (MRMD) CFO details RSU exercises and tax share withholding

Q: How many MariMed (MRMD) shares were withheld for Mario Pinho’s taxes?

The issuer withheld 30,589 shares of MariMed common stock at $0.0662 per share to satisfy Mario Pinho’s tax withholding obligations arising from RSU vesting, as disclosed in the footnotes to the July 15, 2026 Form 4 transactions.

Q: What RSU activity did MariMed (MRMD) CFO Mario Pinho report?

Mario Pinho exercised 88,276 restricted stock units , which convert one-for-one into MariMed common shares. The Form 4 also shows remaining RSUs under grants from July 15, 2024 and April 15, 2026 that will continue vesting in scheduled installments through 2027.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

MariMed Inc. chief financial officer Mario Pinho reported equity-compensation transactions dated July 15, 2026. He exercised 88,276 restricted stock units into common stock and had 30,589 common shares withheld at $0.0662 per share to satisfy tax withholding obligations. After these transactions, he directly holds 365,761 common shares and continues to hold unvested RSUs from grants dated July 15, 2024 and April 15, 2026 that vest in installments through April 15, 2027.

Insider Trade Summary

88,276 shares exercised/converted

Mixed 4 txns

Insider Pinho Mario

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units (RSU)	49,995	$0.00	--
Exercise	Restricted Stock Units (RSU)	38,281	$0.00	--
Exercise	Common stock	88,276	$0.00	--
Tax Withholding	Common stock	30,589	$0.0662	$2K

Holdings After Transaction: Restricted Stock Units (RSU) — 99,990 shares (Direct); Common stock — 365,761 shares (Direct)

Footnotes (1)

RSUs convert to shares of common stock on a one-for-one basis. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs. The RSUs were granted on July 15, 2024; the remaining RSUs under this will grant in two equal installments on each of January 15, 2027 and July 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Key Figures

Shares withheld for taxes: 30,589 shares RSUs converted to common stock: 88,276 shares Common stock holdings after transactions: 365,761 shares +3 more

6 metrics

Shares withheld for taxes 30,589 shares Common stock withheld to satisfy tax withholding obligations on RSU vesting

RSUs converted to common stock 88,276 shares Common shares acquired upon RSU conversion on July 15, 2026

Common stock holdings after transactions 365,761 shares Direct holdings by Mario Pinho following July 15, 2026 activity

Tax withholding share price $0.0662 per share Price applied to shares withheld for tax obligations

RSUs remaining under April 15, 2026 grant 114,844 RSUs Total RSUs remaining after 38,281 units converted; vest through April 15, 2027

RSUs remaining under July 15, 2024 grant 99,990 RSUs Total RSUs remaining after 49,995 units converted; vest in 2027 installments

Key Terms

Restricted Stock Units (RSU), tax withholding obligations, award agreement, par value $.001 per share

4 terms

Restricted Stock Units (RSU) financial

"Transactions include Restricted Stock Units (RSU) converting into common stock."

tax withholding obligations financial

"Shares of common stock withheld to satisfy tax withholding obligations on RSU vesting."

award agreement financial

"RSU vesting follows the terms of an award agreement between issuer and reporting person."

An award agreement is a legal contract that spells out the terms of a pay or equity grant—such as stock options, restricted shares, or cash bonuses—given to an employee, director or consultant. It describes what is being granted, any conditions for keeping it (for example, earning it over time or meeting performance targets), and what happens if the person leaves or breaks rules. Investors care because these agreements affect company costs, potential share dilution and how executives are motivated and rewarded.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/17/2026 - 04:13 PM Accepted by SEC EDGAR 07/17/2026 - 04:12 PM

FAQ

What did MariMed (MRMD) CFO Mario Pinho report in this Form 4?

MariMed CFO Mario Pinho reported equity-compensation activity on July 15, 2026, including exercising 88,276 RSUs into common stock and a 30,589-share tax-withholding disposition, leaving him with 365,761 directly held common shares plus remaining unvested RSUs vesting through 2027.

How many MariMed (MRMD) shares were withheld for Mario Pinho’s taxes?

The issuer withheld 30,589 shares of MariMed common stock at $0.0662 per share to satisfy Mario Pinho’s tax withholding obligations arising from RSU vesting, as disclosed in the footnotes to the July 15, 2026 Form 4 transactions.

How many MariMed (MRMD) shares does Mario Pinho hold after these transactions?

Following the July 15, 2026 transactions, Mario Pinho directly holds 365,761 shares of MariMed common stock. This reflects RSU conversions into common stock and shares withheld to cover tax obligations on the RSU vesting event.

What RSU activity did MariMed (MRMD) CFO Mario Pinho report?

Mario Pinho exercised 88,276 restricted stock units, which convert one-for-one into MariMed common shares. The Form 4 also shows remaining RSUs under grants from July 15, 2024 and April 15, 2026 that will continue vesting in scheduled installments through 2027.

When will Mario Pinho’s remaining MariMed (MRMD) RSUs vest?

Remaining RSUs from an April 15, 2026 grant vest in three equal installments on October 15, 2026, January 15, 2027, and April 15, 2027. RSUs from a July 15, 2024 grant vest in two equal installments on January 15, 2027 and July 15, 2027.

Is MariMed (MRMD) CFO Mario Pinho’s Form 4 tied to a Rule 10b5-1 trading plan?

The Rule 10b5-1 trading plan affirmation box is not checked, and the footnotes describe RSU grants, vesting and tax withholding. The disclosure ties these transactions to equity award vesting rather than to a pre-arranged Rule 10b5-1 trading plan.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pinho Mario

(Last)

(First)

(Middle)

C/O MARIMED INC.

10 OCEANA WAY

(Street)

NORWOOD

MASSACHUSETTS

02062

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/15/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common stock	07/15/2026		M		88,276	A	$0⁽¹⁾	365,761	D
Common stock	07/15/2026		F		30,589⁽²⁾	D	$0.0662	335,172	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (RSU)	⁽¹⁾	07/15/2026		M			49,995	⁽³⁾	⁽³⁾	Common Stock, par value $.001 per share	49,995	$0	99,990	D
Restricted Stock Units (RSU)	⁽¹⁾	07/15/2026		M			38,281	⁽⁴⁾	⁽⁴⁾	Common Stock, par value $.001 per share	38,281	$0	114,844	D

Explanation of Responses:

1. RSUs convert to shares of common stock on a one-for-one basis.

2. Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.

3. The RSUs were granted on July 15, 2024; the remaining RSUs under this will grant in two equal installments on each of January 15, 2027 and July 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

4. The RSUs were granted on April 15, 2026; the remaining RSUs under this grant will vest in three equal installments on each of October 15, 2026, January 15, 2027 and April 15, 2027, in accordance with the terms of an award agreement between the Issuer and the Reporting Person.

Remarks:

	/s/ Mario Pinho	07/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR